Inovalon (Nasdaq: INOV) said it has announced financial results for the second quarter of 2015.
Revenue for the second quarter of 2015 was USD117.6 million, an increase of USD16.6 million, or 17 percent, compared with USD101.0 million for the second quarter of 2014.
Cost of revenue for the second quarter of 2015 was USD33.6 million, or 28.6 percent of revenue, consistent with 28.6 percent of revenue for the second quarter of 2014.
Income from operations for the second quarter of 2015 was USD46.0 million, an increase of USD7.2 million, or 18 percent, compared with USD38.8 million for the second quarter of 2014.
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape.
